272 related articles for article (PubMed ID: 12724617)
1. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.
Droździk M; Białecka M; Myśliwiec K; Honczarenko K; Stankiewicz J; Sych Z
Pharmacogenetics; 2003 May; 13(5):259-63. PubMed ID: 12724617
[TBL] [Abstract][Full Text] [Related]
2. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
3. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis.
Schwab M; Schaeffeler E; Marx C; Fromm MF; Kaskas B; Metzler J; Stange E; Herfarth H; Schoelmerich J; Gregor M; Walker S; Cascorbi I; Roots I; Brinkmann U; Zanger UM; Eichelbaum M
Gastroenterology; 2003 Jan; 124(1):26-33. PubMed ID: 12512026
[TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein drug transporter MDR1 gene polymorphism in renal transplant patients with and without gingival overgrowth.
Drozdzik M; Mysliwiec K; Lewinska-Chelstowska M; Banach J; Drozdzik A; Grabarek J
J Clin Periodontol; 2004 Sep; 31(9):758-63. PubMed ID: 15312098
[TBL] [Abstract][Full Text] [Related]
5. No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects.
Pauli-Magnus C; Feiner J; Brett C; Lin E; Kroetz DL
Clin Pharmacol Ther; 2003 Nov; 74(5):487-98. PubMed ID: 14586389
[TBL] [Abstract][Full Text] [Related]
6. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG
Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
Sills GJ; Mohanraj R; Butler E; McCrindle S; Collier L; Wilson EA; Brodie MJ
Epilepsia; 2005 May; 46(5):643-7. PubMed ID: 15857428
[TBL] [Abstract][Full Text] [Related]
8. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.
Illmer T; Schuler US; Thiede C; Schwarz UI; Kim RB; Gotthard S; Freund D; Schäkel U; Ehninger G; Schaich M
Cancer Res; 2002 Sep; 62(17):4955-62. PubMed ID: 12208746
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance.
Marzolini C; Paus E; Buclin T; Kim RB
Clin Pharmacol Ther; 2004 Jan; 75(1):13-33. PubMed ID: 14749689
[TBL] [Abstract][Full Text] [Related]
10. Association of a polymorphism in the ABCB1 gene with Parkinson's disease.
Westerlund M; Belin AC; Anvret A; Håkansson A; Nissbrandt H; Lind C; Sydow O; Olson L; Galter D
Parkinsonism Relat Disord; 2009 Jul; 15(6):422-4. PubMed ID: 19196542
[TBL] [Abstract][Full Text] [Related]
11. MDR1 gene polymorphisms and clinical relevance.
Li YH; Wang YH; Li Y; Yang L
Yi Chuan Xue Bao; 2006 Feb; 33(2):93-104. PubMed ID: 16529292
[TBL] [Abstract][Full Text] [Related]
12. Effect of MDR1 polymorphism on multidrug resistance expression in breast cancer patients.
Taheri M; Mahjoubi F; Omranipour R
Genet Mol Res; 2010 Jan; 9(1):34-40. PubMed ID: 20082268
[TBL] [Abstract][Full Text] [Related]
13. Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population.
Tahara T; Arisawa T; Shibata T; Hirata I; Nakano H
J Gastroenterol Hepatol; 2007 Oct; 22(10):1678-82. PubMed ID: 17608636
[TBL] [Abstract][Full Text] [Related]
14. Association between the oxidative polymorphism and early onset of Parkinson's disease.
Agúndez JA; Jiménez-Jiménez FJ; Luengo A; Bernal ML; Molina JA; Ayuso L; Vázquez A; Parra J; Duarte J; Coria F
Clin Pharmacol Ther; 1995 Mar; 57(3):291-8. PubMed ID: 7697946
[TBL] [Abstract][Full Text] [Related]
15. Effect of MDR1 gene polymorphism on progression of end-stage renal disease.
Zhang WX; Chen B; Zhang W; Chen N; Yu ZC; Cai WM
Acta Pharmacol Sin; 2007 Apr; 28(4):579-83. PubMed ID: 17376299
[TBL] [Abstract][Full Text] [Related]
16. A polymorphism C3435T of the MDR-1 gene associated with smoking or high body mass index increases the risk of sporadic breast cancer in women.
Zubor P; Lasabova Z; Hatok J; Stanclova A; Danko J
Oncol Rep; 2007 Jul; 18(1):211-7. PubMed ID: 17549370
[TBL] [Abstract][Full Text] [Related]
17. Distribution of allelic variants of functional C3435T polymorphism of drug transporter MDR1 gene in a sample of Polish population.
Jamroziak K; Balcerczak E; Młynarski W; Mirowski M; Robak T
Pol J Pharmacol; 2002; 54(5):495-500. PubMed ID: 12593536
[TBL] [Abstract][Full Text] [Related]
18. Genotype and allele frequencies of MDR1 gene C1236T polymorphism in a Turkish population.
Gümüş-Akay G; Rüstemoğlu A; Karadağ A; Sunguroğlu A
Genet Mol Res; 2008 Oct; 7(4):1193-9. PubMed ID: 19048498
[TBL] [Abstract][Full Text] [Related]
19. C3435T polymorphism of the MDR1 gene is not associated with P-glycoprotein function of leukemic blasts and clinical outcome in patients with acute myeloid leukemia.
Hur EH; Lee JH; Lee MJ; Choi SJ; Lee JH; Kang MJ; Seol M; Jang YE; Lee HJ; Kang IS; Shim SK; Ryu SG; Kang YA; Lee YS; Park CJ; Chi HS; Lee KH
Leuk Res; 2008 Oct; 32(10):1601-4. PubMed ID: 18272218
[TBL] [Abstract][Full Text] [Related]
20. MDR1 gene polymorphisms and risk of gingival hyperplasia induced by calcium antagonists.
Meisel P; Giebel J; Kunert-Keil C; Dazert P; Kroemer HK; Kocher T
Clin Pharmacol Ther; 2006 Jan; 79(1):62-71. PubMed ID: 16413242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]